KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Nu Skin Enterprises (NUS) over the last 17 years, with Q3 2025 value amounting to $251.8 million.

  • Nu Skin Enterprises' Cash & Equivalents rose 1055.36% to $251.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.8 million, marking a year-over-year increase of 1055.36%. This contributed to the annual value of $186.9 million for FY2024, which is 2701.51% down from last year.
  • Nu Skin Enterprises' Cash & Equivalents amounted to $251.8 million in Q3 2025, which was up 1055.36% from $264.2 million recorded in Q2 2025.
  • Nu Skin Enterprises' 5-year Cash & Equivalents high stood at $363.9 million for Q2 2022, and its period low was $186.9 million during Q4 2024.
  • Over the past 5 years, Nu Skin Enterprises' median Cash & Equivalents value was $256.1 million (recorded in 2023), while the average stood at $266.7 million.
  • Per our database at Business Quant, Nu Skin Enterprises' Cash & Equivalents crashed by 3527.37% in 2023 and then surged by 1779.67% in 2025.
  • Quarter analysis of 5 years shows Nu Skin Enterprises' Cash & Equivalents stood at $339.6 million in 2021, then dropped by 22.05% to $264.7 million in 2022, then fell by 3.27% to $256.1 million in 2023, then decreased by 27.02% to $186.9 million in 2024, then soared by 34.73% to $251.8 million in 2025.
  • Its Cash & Equivalents was $251.8 million in Q3 2025, compared to $264.2 million in Q2 2025 and $203.8 million in Q1 2025.